Literature DB >> 15061686

Does paracetamol potentiate the effects of oral anticoagulants?: a literature review.

Isabelle Mahé1, Charles Caulin, Jean-François Bergmann.   

Abstract

Paracetamol (acetaminophen) is the analgesic and antipyretic therapy of choice for patients receiving oral anticoagulation. It is widely used by patients in both prescription and over-the-counter products, resulting in frequent co-prescription with oral anticoagulants, especially in elderly patients. Indeed, older patients are the most likely to receive this combination of drugs because indications for both oral anticoagulation and analgesic therapy increase with age. For many years reports have presented evidence both for and against the idea that paracetamol may potentiate the anticoagulant effect of oral anticoagulants, thus increasing haemorrhagic risk in patients receiving this combination of drugs. This issue has continued to be a matter of debate in recent publications. No clear practical conclusion can be drawn from the studies because of methodological bias and the lack of clinical relevance. No prospective, randomised study assessing the effect of paracetamol on the anticoagulant effect of oral anticoagulants as used in clinical practice (i.e. the types of patients and dosages used in clinical practice) are available in the literature. The implications are considerable since on the one hand, the ingestion of paracetamol may be a cause of altered anticoagulation in patients who regularly take oral anticoagulation and who may have a haemorrhagic risk factor; and on the other hand, paracetamol might be the analgesic drug of choice that can be used without the need for any restrictions in patients receiving oral anticoagulant drugs. A comprehensive search of Medline and EMBASE for studies and case reports from 1966-2002 was performed in order to review the available literature on the interaction between paracetamol and oral anticoagulant drugs. In conclusion, the potential interaction between oral anticoagulant drugs and paracetamol is an important unanswered question, due to the growing incidence of the concomitant use of these drugs and the possible bleeding implications. The association between paracetamol and the occurrence of excessive INR values remains controversial due to lack of prospective clinical studies assessing the effect of the prescription of paracetamol in patients receiving long-term oral anticoagulation in clinical conditions. Such a study is currently ongoing.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15061686     DOI: 10.2165/00002018-200427050-00004

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  33 in total

1.  Acetaminophen and warfarin: undesirable synergy.

Authors:  W R Bell
Journal:  JAMA       Date:  1998-03-04       Impact factor: 56.272

Review 2.  Hemorrhagic complications of anticoagulant treatment.

Authors:  M N Levine; G Raskob; S Landefeld; C Kearon
Journal:  Chest       Date:  2001-01       Impact factor: 9.410

3.  Potentiation of oral anticoagulant therapy by acetaminophen.

Authors:  A M Antlitz; J A Mead; M A Tolentino
Journal:  Curr Ther Res Clin Exp       Date:  1968-10

4.  Effect of chronic hypoxia on detoxication enzymes in rat liver.

Authors:  X Shan; T Y Aw; E R Smith; M Ingelman-Sundberg; B Mannervik; T Iyanagi; D P Jones
Journal:  Biochem Pharmacol       Date:  1992-06-09       Impact factor: 5.858

5.  The effect of rofecoxib on the pharmacodynamics and pharmcokinetics of warfarin.

Authors:  J I Schwartz; K J Bugianesi; D L Ebel; M De Smet; R Haesen; P J Larson; A Ko; R Verbesselt; T L Hunt; R Lins; S Lens; A G Porras; J Dieck; B Keymeulen; B J Gertz
Journal:  Clin Pharmacol Ther       Date:  2000-12       Impact factor: 6.875

6.  No clinically relevant drug interaction between paracetamol and phenprocoumon based on a pharmacoepidemiological cohort study in medical inpatients.

Authors:  Karin Fattinger; Roberto Frisullo; Urspeter Masche; Suzanne Braunschweig; Peter J Meier; Malgorzata Roos
Journal:  Eur J Clin Pharmacol       Date:  2002-02       Impact factor: 2.953

7.  Acute hepatic and renal toxicity from low doses of acetaminophen in the absence of alcohol abuse or malnutrition: evidence for increased susceptibility to drug toxicity due to cardiopulmonary and renal insufficiency.

Authors:  H L Bonkovsky; R E Kane; D P Jones; R E Galinsky; B Banner
Journal:  Hepatology       Date:  1994-05       Impact factor: 17.425

8.  Risk factors for intracranial hemorrhage in outpatients taking warfarin.

Authors:  E M Hylek; D E Singer
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

Review 9.  Demographics, assessment and management of pain in the elderly.

Authors:  Mellar P Davis; Manish Srivastava
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Warfarin and acetaminophen interaction.

Authors:  Markus G Gebauer; Karin Nyfort-Hansen; Philip J Henschke; Alexander S Gallus
Journal:  Pharmacotherapy       Date:  2003-01       Impact factor: 4.705

View more
  3 in total

1.  Paracetamol: a haemorrhagic risk factor in patients on warfarin.

Authors:  I Mahé; N Bertrand; L Drouet; G Simoneau; E Mazoyer; C Bal dit Sollier; C Caulin; J F Bergmann
Journal:  Br J Clin Pharmacol       Date:  2005-03       Impact factor: 4.335

Review 2.  Adverse drug reactions and drug-drug interactions with over-the-counter NSAIDs.

Authors:  Nicholas Moore; Charles Pollack; Paul Butkerait
Journal:  Ther Clin Risk Manag       Date:  2015-07-15       Impact factor: 2.423

Review 3.  COVID-19 Medical and Pharmacological Management in the European Countries Compared to Italy: An Overview.

Authors:  Sergio Pandolfi; Luigi Valdenassi; Geir Bjørklund; Salvatore Chirumbolo; Roman Lysiuk; Larysa Lenchyk; Monica Daniela Doşa; Serafino Fazio
Journal:  Int J Environ Res Public Health       Date:  2022-04-02       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.